Giant-Cell Tumor of Tendon Sheath clinical trials at University of California Health
2 in progress, 1 open to eligible people
Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment
open to eligible people ages 18 years and up
A study to evaluate the long-term risk of hepatic failure with TURALIO™ (pexidartinib) and the mechanism of liver injury based upon liver biopsy information among patients who received or are receiving TURALIO™ (pexidartinib) and experience…
at UCLA
Vimseltinib for Tenosynovial Giant Cell Tumor
“Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”
Sorry, in progress, not accepting new patients
This is a multicenter Phase 3 clinical study, which aims to evaluate the effectiveness of an investigational drug called vimseltinib for the treatment of tenosynovial giant cell tumor (TGCT) in cases where surgical removal of the tumor is not an…
at UC Davis
Our lead scientists for Giant-Cell Tumor of Tendon Sheath research studies include Arun S. Singh, MD.
Last updated: